Johnson & Johnson rolls out new platform to enhance surgical skills

9 April 2018 (Last Updated April 9th, 2018 10:27)

The Johnson & Johnson Institute has introduced a new personalised digital learning platform, C-SATS, for surgeons and hospitals to improve technical skills across robotic, laparoscopic and open surgeries.

The Johnson & Johnson Institute has introduced a new personalised digital learning platform, C-SATS, for surgeons and hospitals to improve technical skills across robotic, laparoscopic and open surgeries.

Expected to result in better outcomes and decreased costs, the performance management platform was created at the University of Washington in the US through an alliance between surgeons, engineers and biostatisticians.

Subscribed surgeons will be able to upload procedural videos that will be assessed by expert surgeons and trained reviewers so that they can offer objective and confidential feedback concerned with technical skills.

“The digital platform will be part of the institute’s on-site and online digital learning offerings designed for surgical training, and will boost the Medical Devices Companies’ digital surgery ecosystem.”

Furthermore, the skill levels are benchmarked and tracked by utilising certain validated tools over time. They are additionally correlated to analyse improvements in outcomes such as blood loss, rates of complication and 30-day readmissions.

Johnson & Johnson Medical Devices Companies Global Education Solutions vice-president Sandra Humbles said: “This scalable platform is powered by data capture, analytics and artificial intelligence, and will enable us to partner with healthcare systems in a differentiated way.

“It will fundamentally change how surgeons learn by giving them the opportunity to anonymously receive input on actual cases to improve their technical skills, which benefits patients, surgeons and health systems.”

The digital platform will be part of the institute’s on-site and online digital learning offerings designed for surgical training, and will boost the Medical Devices Companies’ digital surgery ecosystem.

Johnson & Johnson is developing the ecosystem to capture, analyse and use real-world data on interactions between healthcare providers or patients and its technologies.

This feature is intended to deliver intelligent solutions for more predictable treatment pathway to enhance outcomes.